INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 140 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $3,000 | 0.0% | 1,075 | +239.1% | 0.00% | – |
| Q3 2018 | $3,000 | -82.4% | 317 | -86.7% | 0.00% | – |
| Q2 2018 | $17,000 | +240.0% | 2,385 | +299.5% | 0.00% | – |
| Q4 2017 | $5,000 | – | 597 | +966.1% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 56 | -97.5% | 0.00% | -100.0% |
| Q2 2017 | $28,000 | -73.3% | 2,233 | -77.7% | 0.00% | -80.0% |
| Q1 2017 | $105,000 | -47.2% | 10,020 | -53.7% | 0.01% | -58.3% |
| Q4 2016 | $199,000 | +1709.1% | 21,645 | +2064.5% | 0.01% | +1100.0% |
| Q3 2016 | $11,000 | -98.0% | 1,000 | -97.7% | 0.00% | -97.3% |
| Q2 2016 | $554,000 | +1746.7% | 42,884 | +2128.9% | 0.04% | +1750.0% |
| Q1 2016 | $30,000 | – | 1,924 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 5,406,844 | $52,014,000 | 0.66% |
| ETF MANAGERS GROUP, LLC | 282,268 | $3,255,000 | 0.24% |
| Mirae Asset Global Investments Co., Ltd. | 1,470,996 | $14,151,000 | 0.19% |
| Financial Gravity Companies, Inc. | 4,467 | $42,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 67,200 | $646,000 | 0.04% |
| TCI Wealth Advisors, Inc. | 7,766 | $75,000 | 0.03% |
| Freedom Investment Management, Inc. | 64,741 | $623,000 | 0.03% |
| GAM Holding AG | 83,940 | $808,000 | 0.02% |
| SFMG, LLC | 11,994 | $115,000 | 0.02% |
| SHELL ASSET MANAGEMENT CO | 95,127 | $915,000 | 0.02% |